Timothy S Fenske

Timothy S Fenske

UNVERIFIED PROFILE

Are you Timothy S Fenske?   Register this Author

Register author
Timothy S Fenske

Timothy S Fenske

Publications by authors named "Timothy S Fenske"

Are you Timothy S Fenske?   Register this Author

79Publications

2782Reads

5Profile Views

Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.

Oncologist 2019 Aug 29. Epub 2019 Aug 29.

Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0172DOI Listing
August 2019

What is the standard of care for primary mediastinal B cell lymphoma; R-CHOP or DA-EPOCH-R? - Response to Melani et al.

Br J Haematol 2019 Mar 12;184(5):838-840. Epub 2018 Mar 12.

Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15183DOI Listing
March 2019

Impact of Obesity on Clinical Outcomes of Elderly Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancies.

Biol Blood Marrow Transplant 2019 01 19;25(1):e33-e38. Epub 2018 Sep 19.

Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee Wisconsin. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.08.031DOI Listing
January 2019

Incidence and survival trends in mantle cell lymphoma.

Br J Haematol 2018 06 25;181(5):703-706. Epub 2017 Apr 25.

University of Alabama at Birmingham, Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14699DOI Listing
June 2018

One Pulmonary Lesion, 2 Synchronous Malignancies.

J Investig Med High Impact Case Rep 2018 Jan-Dec;6:2324709618785934. Epub 2018 Jun 28.

Aurora St. Luke's Hospital, Milwaukee, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2324709618785934DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062774PMC
June 2018

Survival of Lymphoma Patients Experiencing Relapse or Progression after an Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2018 05 2;24(5):983-988. Epub 2018 Feb 2.

Division of Hematology, Oncology & Transplantation, University of Minnesota, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.01.015DOI Listing
May 2018

Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma.

Biol Blood Marrow Transplant 2018 01 13;24(1):78-85. Epub 2017 Oct 13.

Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.10.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743624PMC
January 2018

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.

J Clin Oncol 2017 Jul 5;35(20):2260-2267. Epub 2017 May 5.

Daniel J. Landsburg and Anthony R. Mato, University of Pennsylvania; James N. Gerson and Stefan K. Barta, Temple University, Philadelphia, PA; Marissa K. Falkiewicz, Robert Wood Johnson Medical School, New Brunswick; Christina Howlett, Tatyana Feldman, and Anthony R. Mato, Hackensack University Medical Center, Hackensack, NJ; Joseph Maly and Kristie A. Blum, Ohio State University, Columbus; Brian T. Hill, Cleveland Clinic, Cleveland, OH; Shaoying Li and L. Jeffrey Medeiros, MD Anderson Cancer Center, Houston, TX; Pallawi Torka and Francisco Hernandez-Ilizaliturri, Roswell Park Cancer Institute, Buffalo; Jennifer K. Lue and Jennifer E. Amengual, Columbia University, New York, NY; Nishitha M. Reddy, Vanderbilt University, Nashville, TN; Arun Singavi and Timothy S. Fenske, Medical College of Wisconsin, Milwaukee, WI; Julio C. Chavez, Moffitt Cancer Center, Tampa, FL; Jason B. Kaplan, Amir Behdad, and Adam M. Petrich, Northwestern University, Evanston; Adam M. Petrich, AbbVie, North Chicago; David J. Peace, University of Illinois, Urbana; Sunita Nathan, Rush University, Chicago, IL; Martin A. Bast and Julie M. Vose, University of Nebraska, Lincoln, NE; Adam J. Olszewski, Brown University, Providence, RI; Cristiana Costa and Frederick Lansigan, Dartmouth College, Hanover, NH; Oscar Calzada and Jonathon B. Cohen, Emory University, Atlanta, GA; Xavier Rivera and Daniel O. Persky, University of Arizona, Tucson, AZ; and Ryan D. Cassaday, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.2157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366297PMC
July 2017

Effect of Routine Surveillance Imaging on the Outcomes of Patients With Classical Hodgkin Lymphoma After Autologous Hematopoietic Cell Transplantation.

Clin Lymphoma Myeloma Leuk 2017 07 12;17(7):408-414. Epub 2017 May 12.

Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.05.005DOI Listing
July 2017

Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.

J Clin Oncol 2016 09 6;34(26):3141-9. Epub 2016 Jun 6.

Nilanjan Ghosh, Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC; Reem Karmali, Rush University Medical Center; Sonali M. Smith, The University of Chicago, Chicago, IL; Vanderson Rocha, Churchill Hospital, Oxford, United Kingdom; Kwang Woo Ahn, Alyssa DiGilio, and Mehdi Hamadani, Medical College of Wisconsin & Center for International Blood and Marrow Transplant Research; Parameswaran N. Hari and Anita D'Souza, Medical College of Wisconsin; Timothy S. Fenske, Froedtert Memorial Lutheran Hospital, Milwaukee, WI; Veronika Bachanova, University of Minnesota Medical Center, Minneapolis, MN; Ulrike Bacher, University Medicine Goettingen and University Cancer Center Hamburg, Hamburg, Germany; Parastoo Dahi, Memorial Sloan Kettering Cancer Center-Adults, New York, NY; Marcos de Lima, University Hospitals Case Medical Center, Cleveland; Samantha Jaglowski, The Ohio State University Medical Center, Columbus, OH; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Mohamed A. Kharfan-Dabaja, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Tim D. Prestidge, Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand; Bipin N. Savani, Vanderbilt University Medical Center, Nashville, TN; Anna M. Sureda, European Group for Blood and Marrow Transplantation and Hospital Duran I Reynals, Barcelona, Spain; Edmund K. Waller, Winship Cancer Institute, Emory University, Atlanta, GA; Alex F. Herrera, City of Hope National Medical Center, Duarte, CA; Philippe Armand, Dana-Farber Cancer Institute, Boston, MA; Rachel B. Salit, Fred Hutchinson Cancer Research Center, Seattle, WA; and Nina D. Wagner-Johnston, Ephraim Fuchs, and Javier Bolaños-Meade, Johns Hopkins University Sidney Kimmel Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.3476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012706PMC
September 2016

Recent advances in post autologous transplantation maintenance therapies in B-cell non-Hodgkin lymphomas.

World J Transplant 2015 Sep;5(3):81-8

Narendranath Epperla, Timothy S Fenske, Parameswaran N Hari, Mehdi Hamadani, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI 53226,United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5500/wjt.v5.i3.81DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580930PMC
September 2015

Post-transplant lymphoproliferative disorders.

Cancer Treat Res 2015 ;165:305-27

Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-13150-4_13DOI Listing
April 2015

Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission.

Cancer 2014 Jul 7;120(14):2122-9. Epub 2014 Apr 7.

Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28698DOI Listing
July 2014

Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality.

J Clin Oncol 2014 Feb 16;32(4):273-81. Epub 2013 Dec 16.

Timothy S. Fenske and Mehdi Hamadani, Medical College of Wisconsin; Mei-Jie Zhang, Jeanette Carreras, and Parameswaran N. Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI; Ernesto Ayala, H. Lee Moffitt Cancer Center and Research Institute, Tampa; Baldeep M. Wirk, Shands Healthcare and University of Florida, Gainesville, FL; Linda J. Burns, University of Minnesota Medical Center, Fairview, Minneapolis; David J. Inwards, Mayo Clinic Rochester, Rochester, MN; Amanda Cashen, Barnes Jewish Hospital, Washington University School of Medicine, St. Louis, MO; Luciano J. Costa, Medical University of South Carolina, Charleston, SC; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center, San Antonio, TX; Robert P. Gale, Imperial College; Silvia Montoto, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom; Leona A. Holmberg and David G. Maloney, Fred Hutchinson Cancer Research Center, Seattle, WA; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Richard T. Maziarz, Oregon Health and Science University, Portland, OR; Reinhold Munker, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA; Miguel-Angel Perales, Memorial Sloan-Kettering Cancer Center, New York, NY; David A. Rizzieri, Duke University Medical Center, Durham, NC; Harry C. Schouten, Academische Ziekenhuis Maastricht, Maastricht, the Netherlands; Sonali M. Smith, University of Chicago Hospitals, Chicago, IL; Edmund K. Waller, Emory University Hospital, Atlanta, GA; and Ginna G. Laport, Stanford Hospital and Clinics, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.2454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897255PMC
February 2014

Follicular lymphoma: prognostic factors, conventional therapies, and hematopoietic cell transplantation.

Biol Blood Marrow Transplant 2012 Jan;18(1 Suppl):S82-91

Division of Medical Oncology and Centre for Lymphoid Cancer, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.11.012DOI Listing
January 2012

Central nervous system Hodgkin lymphoma: case report and review of the literature.

J Neurooncol 2011 Apr 31;102(2):329-34. Epub 2010 Jul 31.

Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-010-0320-8DOI Listing
April 2011

CD23 expression in follicular lymphoma: clinicopathologic correlations.

Am J Clin Pathol 2011 Jan;135(1):46-53

Dept of Pathology, Medical College of Wisconsin, Milwaukee, 53226, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/AJCP27YWLIQRAJPWDOI Listing
January 2011

Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy.

Int J Hematol 2009 Dec 25;90(5):616-622. Epub 2009 Nov 25.

Division of Neoplastic Diseases and Related Disorders, Medical College of Wisconsin, 9200 W. Wisconsin Avenue, Milwaukee, WI, 53226, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-009-0444-9DOI Listing
December 2009

Treatment of diffuse large B-cell lymphoma of the liver with yttrium-90 microsphere embolization.

Nat Clin Pract Oncol 2008 Nov 16;5(11):677-81. Epub 2008 Sep 16.

Division of Neoplastic Diseases and Related Disorders, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc1227DOI Listing
November 2008

Dominant negative effects of the AML1/ETO fusion oncoprotein.

Cell Cycle 2005 Jan 19;4(1):33-6. Epub 2005 Jan 19.

Department of Internal Medicine, Division of Oncology, Stem Cell Biology Section, Washington University, St. Louis, Missourie, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.4.1.1399DOI Listing
January 2005

Stem cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice.

Proc Natl Acad Sci U S A 2004 Oct 11;101(42):15184-9. Epub 2004 Oct 11.

Stem Cell Biology Section, Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://www.pnas.org/cgi/doi/10.1073/pnas.0400751101
Publisher Site
http://dx.doi.org/10.1073/pnas.0400751101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC524043PMC
October 2004